EW Q2 2020 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$925M-14.9% YoY

Gross Profit

$679M73.4% margin

Operating Income

$221M23.9% margin

Net Income

-$122M-13.2% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-18.0%

Cash Flow

Operating Cash Flow

$231M

Free Cash Flow

$123M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$6.4B

Total Liabilities

$2.6B

Stockholders' Equity

$3.8B

Cash & Equivalents

$904M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$925M	$1.1B	-14.9%
Gross Profit	$679M	$772M	-12.0%
Operating Income	$221M	$271M	-18.3%
Net Income	-$122M	$242M	-150.3%

Revenue Segments

Transcatheter Heart Valves

$594M64%

Critical Care

$164M18%

Surgical Heart Valve Therapy

$161M17%

Transcatheter Mitral And Tricuspid Therapies

$6M1%

Geographic Segments

UNITED STATES

$516M56%

Europe

$205M22%

JAPAN

$107M12%

Rest of World

$97M11%